Fig. 3.
Survival in patients with an initial duration of remission 12 months or less treated at relapse with either high-dose therapy and autografting (solid line, n = 25) or conventional salvage therapy (n = 35, dashed line). (A) Overall survival. Log-rank P = .15. (B) Event-free survival. Log-rank P < .01.